Share >  
Share
Share on Tumblr

Indian Pharma

News »

   latest by relevance
BSE Sensex consolidates; L&T approves bonus issue
May 22, 2013 at 12:56 | Source: Moneycontrol.com
BSE Sensex was consolidating in the afternoon trade. Selective buying was seen in FMCG, pharma, IT and capital goods stocks. Realty and oil&gas stocks were under pressure. L&T announces Q4 results lower than street estimates
Drug prices set to get cheaper, pharma cos worry
May 20, 2013 at 15:41 | Source: CNBC-TV18
CNBC-TV18's Archana Shukla reports that the recently notified Drug Price Control Order (DPCO) will bring down the prices of 348 essential drugs by as much 35-40 percent and may see a rejig in pharma companies' rankings.
Nifty slips below 6200; pharma drags, M&M up 2.3%
May 20, 2013 at 13:00 | Source: Moneycontrol.com
Colgate is down 2.9 percent in trade today. P&G is set to foray into the Indian toothpaste market in June, with the launch of Oral B toothpaste.
New drug price policy: Which pharma cos will feel the heat?
May 20, 2013 at 13:00 | Source: Moneycontrol.com
Brokerage house HSBC has released a note on the new drug price control order (DPCO) and its impact on the Indian pharma companies. The broking firm believes Glaxo Smithkline, Cadila Healthcare, Cipla and Ranbaxy are most likely to be impacted while Sun Pharma and Lupin are least likely to be impacted.
BSE Sensex ends flat; ABB, JM Financial big movers
May 17, 2013 at 15:33 | Source: Moneycontrol.com
Indian shares closed flat on the final day of the week, which otherwise showed a stellar performance led by huge rally in banking, realty, pharma, auto and capital goods stocks
Prefer Dr Reddys, Sun Pharma: Suresh Mahadevan
May 14, 2013 at 15:54 | Source: CNBC-TV18
One can prefer Dr Reddys Laboratories, Sun Pharma over Ranbaxy, says Suresh Mahadevan, MD & Head of Indian Equities at UBS Securities.

Videos »
Drug prices set to get cheaper, pharma cos worry
Prefer Dr Reddys, Sun Pharma: Suresh Mahadevan
Not worried about Re; bet on Exide, Sun Pharma, Bharti: UBS
Glenmark braves challenges to focus on US mkt
Indian pharmas gain on N America boost: Q4 earnings review
more »

Photos »

  /  
News across the web »
Ranbaxy episode to hit drugs carrying India label; tough to secure new contracts
MUMBAI: Indian drug makers, who had built their billion dollar fortunes by exporting generic drugs to the US market, may find it difficult to secure new contracts as the Ranbaxy episode raises questi...
May 22, 2013 at 06:21 | Source: Economic Times
New drug policy to hurt pharma profitability but consumers set to gain
Stepping up its battle for cheaper medicines, the Indian government yesterday issued the Drug Price Control Order 2013, which will bring down the prices by up to 80 percent.At a time when market power...
May 20, 2013 at 08:49 | Source: FirstPost
A diarrhoea vaccine to beat the rest
There is definite cheer on the vaccine front in India. An affordable, indigenously developed vaccine to mitigate the heavy toll that diarrhoea wreaks on people, especially poor children, is round the...
May 19, 2013 at 21:22 | Source: The Hindu BusinessLine
DIPP wants relook of FDI policy in pharma at PM level
New Delhi, May 19: With no let up in multinationals seeking nod to acquire stake in Indian pharma firms despite government putting norms to check it, DIPP has raised concerns stating the FDI policy i...
May 19, 2013 at 14:52 | Source: The Hindu BusinessLine
Japan to invest in smart-tech projects alongside Delhi-Mumbai industrial corridor
India and Japan have decided to further extend their strategic economic cooperation through Japanese investments in new feeder projects alongside the Delhi-Mumbai industrial corridor. The decision to...
May 18, 2013 at 17:32 | Source: DomainB
more »
Interact & exchange stock tips & market info »

Hruday

Platinum Member

19 Followers

Lupin  

Dear Smartian jee: The investors in Lupin and or Sun Pharma should co...

9.01 PM May 15th

MMB Messenger

Platinum Member

172173 Followers

Lupin  

Are you bullish on Indian pharma sector?

12.29 PM May 8th

raregem

Platinum Member

229 Followers

Piramal Enter  

on this front. OTC will continue to bleed with their limited range. ...

9.50 PM May 3rd

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window